Supplementary Tables and Figures from Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor–Resistant, EGFR-Mutated Non–Small Cell Lung Cancer
Authors:
- Pasi A. JännePJPasi A. Jänne
- Christina BaikCBChristina Baik
- Wu-Chou SuWu-Chou Su
- Melissa L. JohnsonMJMelissa L. Johnson
- Hidetoshi HayashiHHHidetoshi Hayashi
- Makoto NishioMNMakoto Nishio
- Dong-Wan KimDKDong-Wan Kim
- Marianna KoczywasMKMarianna Koczywas
- Kathryn A. GoldKGKathryn A. Gold
- Conor E. SteuerCSConor E. Steuer
- Haruyasu MurakamiHMHaruyasu Murakami
- James Chih-Hsin YangJYJames Chih-Hsin Yang
Open Access
- 3 April 2023
- other
- Published by American Association for Cancer Research (AACR)